INTACT INVESTMENT MANAGEMENT INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.

Quarter-by-quarter ownership
INTACT INVESTMENT MANAGEMENT INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$571,000
-77.4%
18,700
-84.8%
0.02%
-78.6%
Q1 2018$2,522,000
-23.1%
123,000
-2.0%
0.10%
-25.8%
Q4 2017$3,278,000
+17.7%
125,500
-19.6%
0.13%
+9.1%
Q3 2017$2,786,000
-20.4%
156,1000.0%0.12%
-21.9%
Q2 2017$3,501,000
+57.9%
156,100
+3.2%
0.16%
+72.2%
Q1 2017$2,217,000
-30.4%
151,200
-7.6%
0.09%
-23.7%
Q4 2016$3,185,000
-40.4%
163,600
-1.4%
0.12%
-41.6%
Q3 2016$5,342,000
+20.4%
166,000
-2.8%
0.20%
+12.2%
Q2 2016$4,436,000
-46.3%
170,800
-29.7%
0.18%
-46.7%
Q1 2016$8,261,000
-69.4%
242,910
+26.5%
0.34%
-71.9%
Q4 2015$26,970,000
-33.7%
192,000
+12.3%
1.20%
-33.8%
Q3 2015$40,698,000
-9.5%
171,020
+5.3%
1.82%
-2.1%
Q2 2015$44,982,000
+19.2%
162,400
+7.6%
1.85%
+21.8%
Q1 2015$37,725,000
+28.7%
150,880
-14.6%
1.52%
+30.5%
Q4 2014$29,306,000
+2.2%
176,600
-10.0%
1.17%
-1.0%
Q3 2014$28,683,000
+7.3%
196,190
-1.5%
1.18%
+8.1%
Q2 2014$26,726,000
+1.2%
199,080
+9.4%
1.09%
-6.3%
Q1 2014$26,413,000
+25.8%
182,010
+8.1%
1.16%
+14.8%
Q4 2013$20,990,000
+11.4%
168,430
-4.2%
1.01%
+2.0%
Q3 2013$18,839,000
-31.0%
175,730
-41.8%
0.99%
-30.8%
Q2 2013$27,303,000302,0201.44%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders